genome editing

Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.

Funding from the Elsa U. Pardee Foundation will allow investigator to study muscle regeneration and cancer.

Scott Soderling, PhD, has founded a Duke spinout company based on a technology developed in his lab that uses the genome-editing tool CRISPR.

The Center for Advanced Genomic Technologies will seek potential therapies for diseases from cancer to schizophrenia.

Ginsburg’s areas of focus include the study of novel paradigms for developing and translating genomic information into medical practice.